March 2022 – Page 2 – Policy & Medicine

Diagnostic Company Reaches False Claims Act Settlement

OPDP Sends “Bad Ad” Warning Letter over PARAGARD Video

California Court Rules that FMV Payments Can Qualify as Illegal Kickbacks

Mallinckrodt Reaches $260 Million Anti-Kickback Settlement

Connecticut Governor Proposes Price Restrictions on Prescription Drugs

CME Webinar Series Guides Clinicians on Individualizing HER2-Positive Breast Cancer Treatment

Policy and Medicine Compliance Update March 2022 Issue Features: Global Regulatory Changes, Oregon Rep Licensure, FDA vs 1st Amendment, and DOJ Yates 2.0

OPDP Sends Warning Letter to CytoDyn Over Promotional Video for Its IND Leronlimab

District of Delaware Rules HRSA Exceeded Its Authority in Issuing 340B Enforcement Letters

CMS Announces New Flexibilities to QPP and MIPS